Colgate-Palmolive Company: Q1 2001 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2001. Colgate-Palmolive Company operates globally in Oral, Personal, and Household Care, as well as Pet Nutrition. The company reported 561,054,759 shares of common stock outstanding as of April 30, 2001.
Key Financial Metrics
| Metric | Q1 2001 | Q1 2000 |
|---|---|---|
| Net Sales | $2,292.6 million | $2,241.8 million |
| Gross Profit | $1,259.8 million | $1,221.2 million |
| Gross Margin | 55.0% | 54.5% |
| Net Income | $267.9 million | $239.9 million |
| Diluted EPS | $0.44 | $0.38 |
| Operating Cash Flow | $344.2 million | $333.6 million |
| Cash and Equivalents | $227.9 million | $206.6 million (Dec 31, 2000) |
| Total Debt (Current + Long-term) | $3,093.8 million | $2,857.1 million (Dec 31, 2000) |
Material Changes vs. Prior Period
- Sales Growth: Worldwide sales increased 3% to $2,292.6 million. This growth was driven by a 7% increase in unit volume, partially offset by unfavorable foreign currency fluctuations.
- Profitability: Net income rose 12% to $267.9 million. Diluted earnings per share increased 16% to $0.44. Earnings Before Interest and Taxes (EBIT) grew 9% to $441.5 million, representing 19.3% of sales compared to 18.0% in the prior year.
- Margin Expansion: Gross profit margin improved to 55.0% from 54.5%, aided by manufacturing streamlining and global sourcing. SG&A expenses as a percentage of sales decreased to 35.7% from 36.4%.
- Regional Performance:
- North America: Sales up 6% on 7% volume growth.
- Latin America: Sales up 3% on 5% volume growth.
- Europe: Sales up 1% (7% volume growth offset by a weakened Euro).
- Asia/Africa: Sales up 4% on 11% volume growth.
- Debt Levels: Net interest expense increased to $43.6 million due to higher average debt levels. The company utilized $358.3 million in debt proceeds during the quarter.
Guidance, Outlook, and Risks
- Accounting Changes: The company adopted SFAS 133 (Derivative Instruments) effective January 1, 2001, with no material impact on financial position. The company plans to adopt EITF Issues 00-14 and 00-25 effective January 1, 2002, expected to impact revenue/expense classification but not net income.
- Market Risks: The company faces exposure to foreign currency exchange rates, interest rates, and commodity price fluctuations. It utilizes derivative instruments (swaps, forwards) to manage these risks. At March 31, 2001, the fair value of interest rate swaps was an $18.6 million asset, while foreign currency forward contracts resulted in a $21.8 million liability.
- Liquidity: Operating cash flow increased 3% year-over-year. Excluding a non-operating tax payment related to a prior divestment, operating cash flow would have increased 13%.
- Management Commentary: Management highlighted strong performance from recently introduced products (e.g., Colgate Total, Actibrush) and continued cost-saving initiatives driving profitability.
Investor Verification Checklist
- Verify the impact of foreign currency fluctuations on reported sales growth, particularly in the Europe segment.
- Review the composition of the $388.0 million in commercial paper classified as long-term debt.
- Monitor the adoption of EITF Issues 00-14 and 00-25 in 2002 for potential changes in revenue recognition classification.
- Assess the effectiveness of cost-reduction programs in maintaining SG&A expense ratios below 36%.
- Confirm the sustainability of the 7% unit volume growth across all geographic regions.